In order to exclude the possibility that SVA enrichment by BORIS is a specific property of K562, myeloid cells, or the female epigenome in general, we conducted ChIP-seq analysis of an unrelated cancer cell line with aberrantly activated BORIS, Delta-47 cells [55]. The gene discussed is CTCFL; the disease is cancer.